NOAR COST Action: Advancing Targeted Alpha Therapy with Astatine-211 for Cancer Treatment

E. Janevik-Ivanovska; J. Gestin; E. Aneheim; S. Lindegren; J. Gaschet; S. Palm; D. Niculae; P. Bouziotis; M. Pruzynski; P. Kolenc; A. I. Jensen; A. Abrunhosa; L. Navarro; H. Jensen; R. Mikolajczak; M. M. Herth; M. Konijnenberg; F. Guerard

NOAR COST Action: Advancing Targeted Alpha Therapy with Astatine-211 for Cancer Treatment

E. Janevik-Ivanovska
, J. Gestin
, E. Aneheim
, S. Lindegren
, J. Gaschet
, S. Palm
, D. Niculae
, P. Bouziotis
, M. Pruzynski
, P. Kolenc
, A. I. Jensen
, A. Abrunhosa
, L. Navarro
, H. Jensen
, R. Mikolajczak
, M. M. Herth
, M. Konijnenberg
, F. Guerard

University of Nantes
University of Gothenburg
Horia Hulubei National Institute of Physics and Nuclear Engineering
Demokritos National Centre for Scientific Research
Institute of Nuclear Chemistry and Technology, Warsaw
University Medical Centre Ljubljana
University of Coimbra
Precirix
Rigshospitalet
National Centre for Nuclear Research
University of Copenhagen
Erasmus University Medical Center

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Journal	European Journal of Nuclear Medicine and Molecular Imaging
Volume	50
Issue number	suppl. 1
Pages (from-to)	S825-S825
ISSN	1619-7070
Publication status	Published - 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

OpenUrl availability

Check availability in DTU Findit

Cite this

Janevik-Ivanovska, E., Gestin, J., Aneheim, E., Lindegren, S., Gaschet, J., Palm, S., Niculae, D., Bouziotis, P., Pruzynski, M., Kolenc, P., Jensen, A. I., Abrunhosa, A., Navarro, L., Jensen, H., Mikolajczak, R., Herth, M. M., Konijnenberg, M., & Guerard, F. (2023). NOAR COST Action: Advancing Targeted Alpha Therapy with Astatine-211 for Cancer Treatment. European Journal of Nuclear Medicine and Molecular Imaging, 50(suppl. 1), S825-S825.

@article{15847f4b868e48ed89afd42c32f75419,

title = "NOAR COST Action: Advancing Targeted Alpha Therapy with Astatine-211 for Cancer Treatment",

author = "E. Janevik-Ivanovska and J. Gestin and E. Aneheim and S. Lindegren and J. Gaschet and S. Palm and D. Niculae and P. Bouziotis and M. Pruzynski and P. Kolenc and Jensen, \{A. I.\} and A. Abrunhosa and L. Navarro and H. Jensen and R. Mikolajczak and Herth, \{M. M.\} and M. Konijnenberg and F. Guerard",

year = "2023",

language = "English",

volume = "50",

pages = "S825--S825",

journal = "European Journal of Nuclear Medicine and Molecular Imaging",

issn = "1619-7070",

publisher = "Springer",

number = "suppl. 1",

}

Janevik-Ivanovska, E, Gestin, J, Aneheim, E, Lindegren, S, Gaschet, J, Palm, S, Niculae, D, Bouziotis, P, Pruzynski, M, Kolenc, P, Jensen, AI, Abrunhosa, A, Navarro, L, Jensen, H, Mikolajczak, R, Herth, MM, Konijnenberg, M & Guerard, F 2023, 'NOAR COST Action: Advancing Targeted Alpha Therapy with Astatine-211 for Cancer Treatment', European Journal of Nuclear Medicine and Molecular Imaging, vol. 50, no. suppl. 1, pp. S825-S825.

TY - ABST

T1 - NOAR COST Action

T2 - Advancing Targeted Alpha Therapy with Astatine-211 for Cancer Treatment

AU - Janevik-Ivanovska, E.

AU - Gestin, J.

AU - Aneheim, E.

AU - Lindegren, S.

AU - Gaschet, J.

AU - Palm, S.

AU - Niculae, D.

AU - Bouziotis, P.

AU - Pruzynski, M.

AU - Kolenc, P.

AU - Jensen, A. I.

AU - Abrunhosa, A.

AU - Navarro, L.

AU - Jensen, H.

AU - Mikolajczak, R.

AU - Herth, M. M.

AU - Konijnenberg, M.

AU - Guerard, F.

PY - 2023

Y1 - 2023

M3 - Conference abstract in journal

SN - 1619-7070

VL - 50

SP - S825-S825

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

IS - suppl. 1

ER -